This article was originally published in The Rose Sheet
Cosmetic, Toiletry and Fragrance Association Associate General Counsel Catherine Beckley has resigned effective June 13. Beckley has been at CTFA for 15 years, working in the legislative and legal departments and as counsel for the CTFA Foundation and Look Good...Feel Better program. Beckley also worked on environmental issues, such as volatile organic compound emission legislation for personal care products in the Northeast and Mid-Atlantic states...
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.